Data_Sheet_4_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Inpatient postpartum contraception provision among individuals with opioid use disorder in Maine, 2016–2023 by Catherine Gelsinger (15391022)

“…<p>To compare trends in inpatient postpartum (IPP) long-acting reversible contraception (LARC) and permanent contraception provision among women with and without opioid use disorder (OUD) in Maine, which has recently seen a decrease in prevalence of maternal OUD.</p> <p>We used diagnosis codes recorded in hospital discharge data to identify deliveries with and without OUD in Maine during 2016–2023. …”

Data_Sheet_8_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Data_Sheet_1_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Table 1_Serum symmetric dimethylarginine concentrations in enalapril- or telmisartan-treated dogs with proteinuric chronic kidney disease.xlsx by Amirah Nasr (20394893)

“…In dogs co-treated with amlodipine, a significant absolute decrease in mean SDMA (−2.29 μg/dL; p = 0.026) occurred at days 7 and 30, while mean creatinine was unchanged and mean SUN increased.…”

Data_Sheet_6_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

“…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”

Image1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.tif by Liu Liu Huang (17339485)

“…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”

Feeding rate and feeding frequency affect growth performance of common snook (Centropomus undecimalis) juveniles reared in the laboratory by Ricardo Luís Mendes de Oliveira (6484895)

“…The experimental design was a 3 × 3 factorial with three feeding frequencies (F2, F4, and F6: two, four, and six daily meals, respectively), three feeding rates (R1, R2.5, and R4: 1.0, 2.5, and 4.0%/day of fish biomass, respectively), and three replicates, totaling nine treatments (F2R1, F2R2.5, F2R4; F4R1, F4R2.5, F4R4; F6R1, F6R2.5, and F6R4). …”

Effects of HDAC8 inhibition on MPNST cell cycle and apoptosis. by Gonzalo Lopez (22820)

“…<p><b>A.</b> PI staining/FACS analyses showing the effect of HDACis (PCI2 0.5μM/48h, PCI3/4 5μM/48h) on human and murine-derived MPNST cell cycle progression. …”

Table2_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

“…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”

Table1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

“…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”

Table_7_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Table_8_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Table_3_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Table_12_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Table_3_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Table_13_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Data_Sheet_1_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Table_13_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”

Data_Sheet_2_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.DOCX by Beatrice Vione (10734998)

“…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”